- Investing Ideas
- /
- Hong Kong Healthcare Potentially Undervalued Companies
Hong Kong Healthcare Potentially Undervalued Companies
Results
69
Companies with a Value score of at least 3, ordered by Value score
69 companies
MediNet Group
Market Cap: HK$18.3m
An investment holding company, provides medical and dental solutions to corporations, insurance companies, and individuals in Hong Kong and the People’s Republic of China.
8161
HK$0.44
7D
-2.2%
1Y
46.7%
Shanghai Pharmaceuticals Holding
Market Cap: HK$62.5b
Shanghai Pharmaceuticals Holding Co., Ltd.
2607
HK$12.35
7D
-1.9%
1Y
14.4%
Pa Shun International Holdings
Market Cap: HK$66.4m
An investment holding company, engages in the pharmaceutical distribution and manufacturing businesses in the People’s Republic of China.
574
HK$0.045
7D
-11.8%
1Y
28.6%
Charmacy Pharmaceutical
Market Cap: HK$629.6m
Engages in the pharmaceutical distribution business in the People’s Republic of China.
2289
HK$5.83
7D
0%
1Y
-32.2%
Wanjia Group Holdings
Market Cap: HK$54.3m
An investment holding company, engages in the wholesale and distribution pharmaceutical business in the Mainland China and Hong Kong.
401
HK$0.097
7D
7.8%
1Y
102.1%
Jinxin Fertility Group
Market Cap: HK$7.9b
An investment holding company, provides assisted reproductive services (ARS) in China and the United States.
1951
HK$2.88
7D
-10.6%
1Y
21.5%
Rici Healthcare Holdings
Market Cap: HK$1.6b
Operates as an investment holding company that operates general hospitals, medical examination centers, medical laboratories, and clinics in the People’s Republic of China.
1526
HK$1.03
7D
-2.8%
1Y
-14.2%
EuroEyes International Eye Clinic
Market Cap: HK$946.1m
Provides vision correction services in Germany, the People’s Republic of China, Denmark, and the United Kingdom.
1846
HK$2.95
7D
-10.9%
1Y
-34.7%
MicroPort Scientific
Market Cap: HK$23.0b
Engages in the innovating, manufacturing, and marketing medical devices globally in the People’s Republic of China, Europe, Middle East and Africa, Japan, and internationally.
853
HK$12.11
7D
-7.0%
1Y
145.1%
Hygeia Healthcare Holdings
Market Cap: HK$9.3b
Offers oncology healthcare services in the People's Republic of China.
6078
HK$14.96
7D
-3.0%
1Y
-23.6%
YSB
Market Cap: HK$6.2b
Develops digital pharmaceutical platform for pharmaceutical companies, distributors, vendors, pharmacies, and primary healthcare institutions in China.
9885
HK$9.13
7D
-11.6%
1Y
24.9%
YSB
Market Cap: HK$6.2b
Develops digital pharmaceutical platform for pharmaceutical companies, distributors, vendors, pharmacies, and primary healthcare institutions in China.
9885
HK$9.13
7D
-11.6%
1Y
24.9%
Gushengtang Holdings
Market Cap: HK$7.7b
An investment holding company, provides healthcare services in the People’s Republic of China.
2273
HK$32.50
7D
-0.7%
1Y
-15.7%
Hygeia Healthcare Holdings
Market Cap: HK$9.3b
Offers oncology healthcare services in the People's Republic of China.
6078
HK$14.96
7D
-3.0%
1Y
-23.6%
Guangzhou Baiyunshan Pharmaceutical Holdings
Market Cap: HK$44.8b
Researches, develops, manufactures, and sells Chinese patent and Western medicines, chemical raw materials, natural and biological medicines, and intermediates of chemical raw materials.
874
HK$18.10
7D
-2.6%
1Y
-6.9%
Shanghai Pioneer Holding
Market Cap: HK$2.3b
An investment holding company, engages in marketing, promotion, and channel management of pharmaceutical products and medical devices primarily in the People’s Republic of China.
1345
HK$2.00
7D
-1.5%
1Y
-4.8%
Town Health International Medical Group
Market Cap: HK$1.8b
An investment holding company, provides healthcare and related services in the People’s Republic of China and Hong Kong.
3886
HK$0.26
7D
0%
1Y
-3.7%
Sisram Medical
Market Cap: HK$2.4b
Engages in the research, design, development, manufacture, sale, and marketing of medical aesthetics and dental equipment, home use devices, injectables, and cosmeceuticals products in the Asia Pacific, Europe, North America, Latin America, the Middle East, and Africa.
1696
HK$5.22
7D
-11.2%
1Y
62.6%
Yunkang Group
Market Cap: HK$1.3b
Operates as a medical operation service provider in the People's Republic of China.
2325
HK$2.19
7D
-8.0%
1Y
-72.6%
Gushengtang Holdings
Market Cap: HK$7.7b
An investment holding company, provides healthcare services in the People’s Republic of China.
2273
HK$32.50
7D
-0.7%
1Y
-15.7%
Hygeia Healthcare Holdings
Market Cap: HK$9.3b
Offers oncology healthcare services in the People's Republic of China.
6078
HK$14.96
7D
-3.0%
1Y
-23.6%
Kato (Hong Kong) Holdings
Market Cap: HK$445.0m
An investment holding company, operates as a residential care home for the elderly primarily in Hong Kong.
2189
HK$0.45
7D
2.3%
1Y
-16.0%
Wuhan Dazhong Dental Medical
Market Cap: HK$725.9m
Operates as a dental services provider in Central China with a focus on Hubei and Hunan provinces.
2651
HK$14.70
7D
-2.8%
1Y
n/a
C-MER Medical Holdings
Market Cap: HK$2.5b
An investment holding company, provides ophthalmic services under the C-MER Dennis Lam brand name in Hong Kong and Mainland China.
3309
HK$2.01
7D
-2.4%
1Y
-9.5%
Gushengtang Holdings
Market Cap: HK$7.7b
An investment holding company, provides healthcare services in the People’s Republic of China.
2273
HK$32.50
7D
-0.7%
1Y
-15.7%
Mega Genomics
Market Cap: HK$1.6b
A genetic testing platform company, provides consumer genetic testing and cancer screening services in China.
6667
HK$7.20
7D
0%
1Y
-27.3%
Xikang Cloud Hospital Holdings
Market Cap: HK$816.6m
An investment holding company, primarily provides cloud hospital platform services in the People's Republic of China and internationally.
9686
HK$0.97
7D
-4.0%
1Y
31.1%
New Horizon Health
Market Cap: HK$6.3b
An investment holding company, engages in the research and development of screening products for colorectal, cervical, and other types of cancer in the People’s Republic of China.
6606
HK$14.14
7D
0%
1Y
-52.3%
Suzhou Basecare Medical
Market Cap: HK$1.1b
An investment holding company provides genetic testing solutions for assisted human reproduction in the People’s Republic of China and Australia.
2170
HK$3.88
7D
6.6%
1Y
148.7%
Guangzhou Baiyunshan Pharmaceutical Holdings
Market Cap: HK$44.8b
Researches, develops, manufactures, and sells Chinese patent and Western medicines, chemical raw materials, natural and biological medicines, and intermediates of chemical raw materials.
874
HK$18.10
7D
-2.6%
1Y
-6.9%
Kelfred Holdings
Market Cap: HK$98.0m
An investment holding company, engages in the manufacture and sale of eyewear products in the People’s Republic of China, Italy, the United Kingdom, the Netherlands, Hong Kong, France, Japan, Australia, the United States, and internationally.
1134
HK$0.20
7D
-1.0%
1Y
-30.0%
Guangzhou Baiyunshan Pharmaceutical Holdings
Market Cap: HK$44.8b
Researches, develops, manufactures, and sells Chinese patent and Western medicines, chemical raw materials, natural and biological medicines, and intermediates of chemical raw materials.
874
HK$18.10
7D
-2.6%
1Y
-6.9%
YSB
Market Cap: HK$6.2b
Develops digital pharmaceutical platform for pharmaceutical companies, distributors, vendors, pharmacies, and primary healthcare institutions in China.
9885
HK$9.13
7D
-11.6%
1Y
24.9%